Platelet-Rich Plasma Therapy Worth A Trial In Temporomandibular Joint Osteoarthritis
- byDoctor News Daily Team
- 15 July, 2025
- 0 Comments
- 0 Mins
Platelet-rich plasma therapy is worth a trial in temporomandibular joint osteoarthritis suggests a new study published in the Journal of Cranio-Maxillofacial Surgery.
The study aimed to compare the efficacy of platelet-rich plasma (PRP) injections for the treatment of temporomandibular joint osteoarthritis (TMJ-OA) with hyaluronic acid (HA) therapy. This randomized controlled trial included 70 patients with temporomandibular joint-OA, randomly divided into either a Platelet-rich plasma or hyaluronic acid (HA) group. The pain intensity, maximum mouth opening (MMO), TMJ sound score, and proportion of crepitus were recorded and compared at baseline and at 1, 3, and 6 months. Both groups showed statistically significant improvements in pain intensity, MMO, TMJ sound, and scale scores during the 6-month follow-up period. The improvements in pain intensity during mouth opening at 1 month, MMO at 1, 3, and 6 months, temporomandibular joint sound score at 1 and 3 months, and GAD-7 score at 6 months in the PRP group were greater than in the HA group (p < 0.05). Compared with the HA group, imaging improvement in the PRP group was also higher (p < 0.05).
Researchers found that Platelet-rich plasma injection resulted in a more significant improvement in short-term (1 month) mouth opening pain compared with HA injection therapy, and in short-to-long-term maximum mouth opening.The repair effect of PRP injection therapy on the condylar bone was superior to that of HA. In addition, PRP injection therapy was conducive to alleviating anxiety in patients.
Within the limitations of the study it seems that the application of Platelet-rich plasma therapy in temporomandibular joint- osteoarthritis should be considered whenever possible.
Reference:
Sha-Sha Liu, Li-Li Xu, Li-Kun Liu, Shen-Ji Lu, Bin Cai. Platelet-rich plasma therapy for temporomandibular joint osteoarthritis: A randomized controlled trial. Journal of Cranio-Maxillofacial Surgery, Volume 51, Issue 11, 2023, Pages 668-674, ISSN 1010-5182,
https://doi.org/10.1016/j.jcms.2023.09.014
Keywords:
Platelet-rich, plasma, therapy, worth, trial, temporomandibular, joint osteoarthritis, Journal of Cranio-Maxillofacial Surgery, Platelet-rich plasma; Injection; Hyaluronic acid; Temporomandibular joint; Osteoarthritis
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Sleeping with Low Pillow Height May Increase Risk...
- 05 November, 2025
Novel Blood Test May Offer definitive diagnosis fo...
- 05 November, 2025
Esmolol Outperforms Landiolol in Reducing Mortalit...
- 05 November, 2025
Max Healthcare and Tata Institute for Genetics and...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!